Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study

被引：0
|
作者：
Rossing, Peter
Agarwal, Rajiv
Anker, Stefan
Filippatos, Gerasimos
Pitt, Bertram
Ruilope, Luis M.
Chan, Juliana C.
Kooy, Adriaan
Mccafferty, Kieran
Schernthaner, Guntram
Wanner, Christoph
Joseph, Amer
Scheerer, Markus F.
Scott, Charlie
Bakris, George
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-14-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14-LB
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIODKD Study
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Chan, Juliana
    Kooy, Adriaan
    McCafferty, Kieran
    Schernthaner, Guntram
    Wanne, Christoph
    AMERICAN HEART JOURNAL, 2021, 242 : 160 - 161
  • [2] Effect of Finerenone on CKD Outcomes in Type 2 Diabetes: A Chinese Subgroup Analysis of the FIDELIO-DKD Study
    Zhang, Haitao
    Xie, Jingyuan
    Hao, Chuanming
    Li, Xuemei
    Zhu, Dalong
    Zheng, Hongguang
    Xu, Xudong
    Mo, Zhaohui
    Lu, Weiping
    Lu, Yibing
    Wu, Chaoqing
    Tong, Nanwei
    Wang, Li
    Liu, Zhihong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 678 - 678
  • [3] Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
    Flack, John M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Adler, Sharon G.
    Fried, Linda
    Jamerson, Kenneth
    Toto, Robert
    Brinker, Meike
    Farjat, Alfredo E.
    Kolkhof, Peter
    Lawatscheck, Robert
    Joseph, Amer
    Bakris, George L.
    KIDNEY MEDICINE, 2023, 5 (12)
  • [4] Cardiorenal Outcomes With Finerenone in Asian Patients With CKD and Type 2 Diabetes: Post Hoc Analysis From FIDELIO-DKD
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Lee, Byung-Wan
    Lee, Chien-Te
    Liu, Zhi Hong
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 678 - 678
  • [5] Importance of trial design when investigating cardiorenal outcomes in patients with CKD and T2D: Focus on CREDENCE and FIDELIO-DKD
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Boletis, John
    Toto, Robert
    Umpierrez, Guillermo E.
    Wanner, Christoph
    Wada, Takashi
    Scott, Charlie
    Joseph, Amer
    Ogbaa, Ike
    Ro, Luke
    AMERICAN HEART JOURNAL, 2021, 242 : 162 - 162
  • [6] SGLT2i Use and the Risk of Nephrolithiasis in Patients with T2D
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary
    Mastrorilli, Julianna M.
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [7] FIDELIO-DKD Study: Analysis of Effects of Finerenone by Baseline A1C
    Rossing, Peter
    Burgess, Ellen
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Gillard, Pieter
    Joseph, Amer
    Brinker, Meike Daniela
    Scott, Charlie
    Bakris, George
    DIABETES, 2021, 70
  • [8] Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D
    Gonzalez-Albarran, Olga
    Morales, Cristobal
    Perez-Maraver, Manuel
    Juan Aparicio-Sanchez, Jose
    Simo, Rafael
    DIABETES THERAPY, 2022, 13 (SUPPL 1) : 35 - 49
  • [9] Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D
    Olga González-Albarrán
    Cristóbal Morales
    Manuel Pérez-Maraver
    José Juan Aparicio-Sánchez
    Rafael Simó
    Diabetes Therapy, 2022, 13 : 35 - 49
  • [10] Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China
    Zhang, Haitao
    Xie, Jingyuan
    Hao, Chuanming
    Li, Xuemei
    Zhu, Dalong
    Zheng, Hongguang
    Xu, Xudong
    Mo, Zhaohui
    Lu, Weiping
    Lu, Yibing
    Wu, Chaoqing
    Tong, Nanwei
    Wang, Li
    Liu, Zhihong
    KIDNEY DISEASES, 2023, 9 (06) : 498 - 506
12345